HemaSphere (Oct 2022)
P097: The status quo of involved-field radiotherapy – Quality analysis of radiotherapy in the GHSG HD 16
- Michael Oertel,
- Dominik Hering,
- Christopher Kittel,
- Nina Nacke,
- Kai Kröger,
- Jan Kriz,
- Michael Fuchs,
- Christian Baues,
- Dirk Vordermark,
- Rita Engenhart-Cabillic,
- Klaus Herfarth,
- Peter Lukas,
- Heinz Schmidberger,
- Simone Marnitz,
- Peter Borchmann,
- Uwe Haverkamp,
- Andreas Engert,
- Hans Theodor Eich
Affiliations
- Michael Oertel
- 1 Department of Radiation Oncology - University Hospital Muenster, Muenster, Germany
- Dominik Hering
- 1 Department of Radiation Oncology - University Hospital Muenster, Muenster, Germany
- Christopher Kittel
- 1 Department of Radiation Oncology - University Hospital Muenster, Muenster, Germany
- Nina Nacke
- 1 Department of Radiation Oncology - University Hospital Muenster, Muenster, Germany
- Kai Kröger
- 1 Department of Radiation Oncology - University Hospital Muenster, Muenster, Germany
- Jan Kriz
- 2 Department of Radiation Oncology, Alexianer Clemenshospital Muenster, Muenster, Germany
- Michael Fuchs
- 3 Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf, University Hospital of Cologne, Cologne, Germany
- Christian Baues
- 4 Department of Radiation Oncology and Cyberknife Center, University Hospital of Cologne, Cologne, Germany
- Dirk Vordermark
- 5 Department of Radiation Oncology, University Hospital Halle (Saale), Halle (Saale), Germany
- Rita Engenhart-Cabillic
- 6 Department of Radiotherapy and Radiation Oncology, University Hospital Giessen-Marburg, Marburg, Germany
- Klaus Herfarth
- 7 Department of Radiation Oncology, Heidelberg University Hospital, Heidelberg, Germany
- Peter Lukas
- 8 Department of Radiooncology, Medical University Innsbruck, Innsbruck, Austria
- Heinz Schmidberger
- 9 Department of Radiotherapy and Radiation Oncology, University Hospital Mainz, Mainz, Germany
- Simone Marnitz
- 4 Department of Radiation Oncology and Cyberknife Center, University Hospital of Cologne, Cologne, Germany
- Peter Borchmann
- 3 Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf, University Hospital of Cologne, Cologne, Germany
- Uwe Haverkamp
- 1 Department of Radiation Oncology - University Hospital Muenster, Muenster, Germany
- Andreas Engert
- 3 Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf, University Hospital of Cologne, Cologne, Germany
- Hans Theodor Eich
- 1 Department of Radiation Oncology - University Hospital Muenster, Muenster, Germany
- DOI
- https://doi.org/10.1097/01.HS9.0000890956.78190.fc
- Journal volume & issue
-
Vol. 6
pp. 44 – 45
Abstract
No abstracts available.